Milroy disease and the VEGFR-3 mutation phenotype

被引:113
作者
Brice, G
Child, AH
Evans, A
Bell, R
Mansour, S
Burnand, K
Sarfarazi, M
Jeffery, S
Mortimer, P
机构
[1] St George Hosp, Sch Med, SW Thames Reg Genet Unit, London SW17 0RE, England
[2] St George Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England
[3] St Thomas Hosp, Acad Dept Surg, London, England
[4] Univ Connecticut, Ctr Hlth, Mol Ophthalm Genet Lab, Farmington, CT USA
[5] St George Hosp, Sch Med, Dept Cardiac & Vasc Sci Dermatol, London SW17 0RE, England
关键词
D O I
10.1136/jmg.2004.024802
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Primary congenital lymphoedema ( Milroy disease) is a rare autosomal dominant condition for which a major causative gene defect has recently been determined. Mutations in the vascular endothelial growth factor receptor 3 ( VEGFR-3) gene have now been described in 13 families world-wide. This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in VEGFR-3. Ninety per cent of the 71 individuals carrying a VEGFR-3 mutation showed signs of oedema, which was confined in all cases to the lower limbs. In all but two cases onset of swelling was from birth. Other symptoms and signs included cellulitis (20%), large calibre leg veins (23%), papillomatosis (10%), and upslanting toenails ( 10%). In males, hydrocoele was the next most common finding after oedema (37%). Thorough clinical examination of these patients indicates that there are few clinical signs in addition to lower limb oedema. Rigorous phenotyping of patients produces a high yield of VEGFR-3 mutations..
引用
收藏
页码:98 / 102
页数:5
相关论文
共 26 条
[1]  
[Anonymous], 1901, The Principles and Practice of Medicine, Designed for the Use of Practitioners and Students of Medicine
[2]   Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene [J].
Bell, R ;
Brice, G ;
Child, AH ;
Murday, VA ;
Mansour, S ;
Sandy, CJ ;
Collin, JRO ;
Brady, AF ;
Callen, DF ;
Burnand, K ;
Mortimer, P ;
Jeffery, S .
HUMAN GENETICS, 2001, 108 (06) :546-551
[3]  
BOLLINGER A, 1983, LYMPHOLOGY, V16, P27
[4]   Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24 [J].
Brice, G ;
Mansour, S ;
Bell, R ;
Collin, JR ;
Child, AH ;
Brady, AF ;
Sarfarazi, M ;
Burnand, KG ;
Jeffery, S ;
Mortimer, P ;
Murday, VA .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (07) :478-483
[5]  
BURNAND KG, 2003, DIS LYMPHATICS, P110
[6]  
BURNAND KG, 2003, DIS LYMPHATICS, P123
[7]   Cardiovascular failure in mouse embryos deficient in VEGF receptor-3 [J].
Dumont, DJ ;
Jussila, L ;
Taipale, J ;
Lymboussaki, A ;
Mustonen, T ;
Pajusola, K ;
Breitman, M ;
Alitalo, K .
SCIENCE, 1998, 282 (5390) :946-949
[8]   Mapping of primary congenital lymphedema to the 5q35.3 region [J].
Evans, AL ;
Brice, G ;
Sotirova, V ;
Mortimer, P ;
Beninson, J ;
Burnand, K ;
Rosbotham, J ;
Child, A ;
Sarfarazi, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (02) :547-555
[9]   Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema [J].
Evans, AL ;
Bell, R ;
Brice, G ;
Comeglio, P ;
Lipede, C ;
Jeffery, S ;
Mortimer, P ;
Sarfarazi, M ;
Child, AH .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (09) :697-703
[10]   Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome [J].
Fang, JM ;
Dagenais, SL ;
Erickson, RP ;
Arlt, MF ;
Glynn, MW ;
Gorski, JL ;
Seaver, LH ;
Glover, TW .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (06) :1382-1388